Congressional negotiators agree to keep funding COVID tests, therapeutics, but not global response
Late Monday, Congressional negotiators said they have a deal to repurpose previously approved federal spending that will keep the federal government paying for therapeutics, COVID-19 tests, vaccines and personal protective equipment supplies. Some funding had already ended while other funding ends this week. Congress may not be able to act fast enough to stop an interruption.
The $10 billion compromise is half of what the Biden administration wanted.
The agreement does not include more money to support the global response which health experts say is short-sighted, especially considering how COVID-19 is still causing big problems in other parts of the world. Keep in mind that many countries have barely vaccinated their populations.
The negotiators aimed to find a way to keep vaccine production running and keep testing available. The so-called “repurposed” funds come from a half-billion dollars originally earmarked to support colleges and universities during COVID-19 and another $1 billion that had been set aside for tribal governments.
Congress has waited until the last minute to come to this point. As ABC News points out:
Last week, for example, the White House warned that without any funding, the nation would only have enough tests to get through the next potential increase of cases from the BA.2 variant but wouldn't be able to keep producing tests at the current pace after June.
And in the time Congress and the White House have spent squabbling over the funding, the uninsured fund ran out of money, leaving Americans who don't have insurance to pay as much as $125 out of pocket if they get PCR testing at labs like Quest Diagnostics, one of the biggest in the country
Funds to cover the costs of vaccination for uninsured Americans are set to run out this week.
Monoclonal antibody treatment supplies distributed to states each week have also already been impacted. And Biden warned that the U.S. supply could run out entirely by May if funding isn't secured.
"We've had to cancel planned orders and cut the supply we're sending to the states. Without more funding, we'll start to run out of them by the end of May," he said on Wednesday.
On top of those deadlines, the Senate usually dismisses for a two-week Easter recess.
Not insured? Here is what COVID tests will cost you out of pocket
While Congress sorts out the COVID-19 spending bill that negotiators approved yesterday, people without insurance are stuck paying for testing. If you have no insurance and want a PCR test, this is what ABC News says you will pay:
Quest Diagnostics, one of the largest testing companies in the country, told ABC News that patients who are not on Medicare, Medicaid or a private health plan will now be charged $125 dollars ($119 and a $6 physician fee) when using one of its QuestDirect PCR tests either by ordering a kit online or visiting one of the 1,500 Quest or major retail locations that administer the tests, such as Walmart or Giant Eagle.
This week, federal funding to cover the cost of COVID-19 testing and treatment for uninsured Americans officially dried up; any further infusion of cash hinges on Congress passing the White House's request for billions more in COVID relief, which is still stuck at an impasse.
Quest has begun notifying its clients and partners they can no longer expect to be reimbursed for uninsured claims, barring additional funding from Congress.
30 million Americans have no health insurance. Health care strategists say making testing costly to millions of Americans will make them reluctant to get tested and make it more difficult to track the virus throughout the year.
The COVID ‘emergency’ expires April 15, but hospitals execs want it extended
Eight hospital groups plus the American Hospital Association sent a letter to Health and Human Services Secretary Xavier Becerra urging him to renew the Public Health Emergency declaration that will expire April 15. The hospitals say they need the PHE designation to deal with shortages of essential medical supplies and staffing. The hospitals also say that even while the pandemic’s effects are less now, there is a backlog of medical cases that were delayed by the pandemic.
The hospitals listed a number of ways that they get relief by the country being under the health emergency designation:
The PHE declaration allows you to take certain actions in response to the COVID-19 pandemic. These include waivers of certain Medicare, Medicaid, CHIP, and HIPAA Privacy Rule requirements, such as: conditions of participation; staff licensure requirements for practicing in other states; limitations from liability for certain providers; sanctions under the Emergency Medical Treatment and Labor Act for direction or relocation of an individual; important telehealth waivers; and deadlines and time tables for performance of required activities, such as quality reporting. Also, the additional 6.2% in Federal Medical Assistance Percentage funding for the state Medicaid programs, designated in the Families First Coronavirus Relief Act, is tied to the length of the PHE and the continuous coverage requirement has been essential in helping provide health care coverage to vulnerable populations during the economic downturn.
HHS has extended the PHE eight times since Jan. 27, 2020, with the most recent renewal in January 2022. The hospital groups want an extension past the end of this month.
The COVID-diabetes connection
The New York Times opened a story with this statement:
After older people and nursing home residents, no group perhaps has been harder hit by the pandemic than people with diabetes. Experts hope policymakers will take notice, and finally get serious about tackling the nation’s diabetes crisis.
More than one-third of people who died from COVID-19 also had diabetes, according to this new study. Of course, that statistic may have more layers than it seems since diabetes is linked to so many other factors, such as obesity and high blood pressure.
Look at the data and see what the demographics of people who died from COVID-19 had in common, including age, gender and diabetes.
The mean age of people hospitalized for COVID-19 was 71.1 ± 12.9 years,
63.6% were males
75.6% had type 2 diabetes
4.6% had type 1 diabetes
19.8% had prediabetes.
The Times story lays out why we should pay attention to the significant vulnerabilities that people with diabetes face, especially in a pandemic:
“It’s hard to overstate just how devastating the pandemic has been for Americans with diabetes,” said Dr. Giuseppina Imperatore, who oversees diabetes prevention and treatment at the Centers for Disease Control and Prevention.
Diabetes patients hospitalized with Covid spend more time in the I.C.U., are more likely to be intubated and are less likely to survive, according to several studies, one of which found that 20 percent of hospitalized coronavirus patients with diabetes died within a month of admission. Though researchers are still trying to understand the dynamics between the two diseases, most agree on one thing: Uncontrolled diabetes impairs the immune system and decreases a patient’s ability to withstand a coronavirus infection.
Diabetes is a pernicious disease that is at once ubiquitous and invisible, partly because most people with the condition do not appear outwardly ill. It affects 34 million Americans, or 13 percent of all adults, but draws less funding and public attention than other major killers like cancer, Alzheimer’s and heart disease.
The COVID-19/diabetes connection also helps to explain why Black and Hispanic patients fared worse in the pandemic, since they are also disproportionally experiencing diabetes.
US nursing home deaths from COVID hit new low
Here is some encouraging news. The CDC’s latest data shows nursing home deaths from COVID-19 have hit a new pandemic low.
